Seroprevalence and biochemical parameters among patients with Chikungunya in Adamaoua region, Cameroon: A cross-sectional study

喀麦隆阿达马瓦地区基孔肯雅热患者的血清阳性率和生化指标:一项横断面研究

阅读:1

Abstract

BACKGROUND: Chikungunya virus (CHIKV) infection is a vector-borne febrile illness endemic to Africa. In Cameroon, few studies have documented human exposure to CHIKV, especially in the Adamaoua region. This study aimed to assess the CHIKV seroprevalence in Ngaoundere city and analyze likely association with social, clinical, and biochemical determinants. METHODS: A cross-sectional study was conducted at the Ngaoundere Regional Hospital from July to October 2022. The sociodemographic and clinical informations of participants were recorded using a standardized questionnaire. Then, blood tests were performed to determine the CHIKV status, the transaminase, and lipid profiles. RESULTS: Of the 200 persons surveyed, 21.5% (43) were positive for anti-CHIKV IgM antibodies. Age, sex, occupation, marital status, level of study, and place of residence were not significantly associated with CHIKV. However, fever (RR = 4.19; 42.86%; p = 0.0124), headaches (RR = 4.89; 50%; p = 0.0007), digestive disorders (RR = 6.52; 66.67%; p = 0.0001), and the presence of at least two clinical symptoms (RR = 2.55; 26.09%; p = 0.009) were significantly correlated with the presence of CHIKV compared with the absence of clinical symptoms (RR = 1, 10.23%). Similarly, cases of CHIKV were significantly more important in subjects with high aspartate aminotransferase (AST) than in those with normal AST (RR = 2.45; 37.50% vs. 15.28%; p = 0.0006). No significant association was found between alanine-aminotransferase and lipid profile markers. CONCLUSION: Ngaoundere populations seem to be commonly infected with CHIKV, increasing the incidence of febrile symptoms and transaminase elevation. Clinical and metabolic monitoring is required.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。